Joseph M Macaitis
Overview
Explore the profile of Joseph M Macaitis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
31
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guda T, Stukel Shah J, Lundquist B, Macaitis J, Perez M, Pfau-Cloud M, et al.
J Biomed Mater Res B Appl Biomater
. 2024 Nov;
112(12):e35516.
PMID: 39607370
A combined biomaterial and cell-based solution to heal critical size bone defects in the craniomaxillofacial area is a promising alternative therapeutic option to improve upon autografting, the current gold standard....
2.
Klemcke H, Delgado A, Holcomb J, Ryan K, Burke A, DeGuzman R, et al.
J Trauma
. 2005 Aug;
59(1):155-61.
PMID: 16096556
Background: Previous experiments with diverse pig models to evaluate the ability of rFVIIa to reduce hemorrhage have provided divergent results. The current study was conducted to address concerns related to...
3.
Dubick M, Brooks D, Macaitis J, Bice T, Moreau A, Holcomb J
Mil Med
. 2005 Feb;
170(1):76-82.
PMID: 15724859
The fluid-warming capabilities of four individual fluid warmers, i.e., Level 1, FMS 2000, Thermal Angel, and Ranger, were compared to evaluate their potential for medical use in forward military echelons...
4.
Schreiber M, Holcomb J, Hedner U, Brundage S, Macaitis J, Aoki N, et al.
J Am Coll Surg
. 2003 May;
196(5):691-7.
PMID: 12742197
Background: Recombinant Factor VIIa (rFVIIa) has been used to decrease bleeding in a number of settings, including hemophilia, liver transplantation, intractable bleeding, and cirrhosis. It has also been shown to...
5.
Schreiber M, Holcomb J, Hedner U, Brundage S, Macaitis J, Hoots K
J Trauma
. 2002 Aug;
53(2):252-7; discussion 257-9.
PMID: 12169930
Background: Recombinant factor VIIa (rFVIIa) has been used to decrease bleeding in a number of settings including hemophilia, liver transplantation, intractable bleeding, and cirrhosis. Experience in the trauma setting is...